Related Experiment Video
Updated: May 22, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Stevens-Johnson syndrome induced by sodium valproate monotherapy
Kn Naveen1, Js Arunkumar, K Hanumanthayya
1Department of Dermatology, Shri Dharamasthala Manjunatheshwara College of Medical Sciences and Hospital, Sattur, Dharwad - 580 009, India.
Abstract:
A case of Stevens-Johnson syndrome following treatment with sodium valproate is presented here. A 20-year-old male was put on sodium valproate monotherapy for the migraine, with generalized epilepsy. He developed vesicles and bullae in the oral and nasal mucosa with conjunctivitis, after 10 days of treatment. The lesions resolved after treating with systemic steroids. This case has been presented because Stevens-Johnson syndrome with sodium valproate monotherapy has been very rarely reported.
Related Concept Videos
Drug toxicity: Idiosyncratic Reactions
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Glutamate Antagonists
Drug Toxicity: Risk factors

